DMAC EPS Estimates
DiaMedica Therapeutics Inc.
$8.01
+$0.02(+0.25%)
50
Overall
40
Value
75
Tech
36
Quality
Market Cap
$430.87M
Volume
240.27K
52W Range
$5.25 - $10.42
Target Price
$15.50
DMAC EPS estimates: the consensus estimate for DiaMedica Therapeutics Inc.'s current fiscal year is -$0.84 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
DMAC EPS Estimates
- EPS estimate, current quarter
- $-0.20
- EPS estimate, next quarter
- $-0.22
- EPS estimate, current year
- $-0.84
- EPS estimate, next year
- $-0.81
- EPS growth, 3-year
- -10.42%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.70 |
| 2024 | $-0.60 |
| 2023 | $-0.60 |
| 2022 | $-0.52 |
| 2021 | $-0.65 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DMAC | $8.01 | +0.3% | 240.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get DiaMedica Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW